INSULIN GLARGINE 300U/ML AND INSULIN GLARGINE 100U/ML SHOW EQUIPOTENT IN VIVO BLOOD GLUCOSE LOWERING WHEN ADMINISTERED INTRAVENOUSLY IN DOGS

被引：0
|
作者：
Werner, U. [1 ]
Korn, M. [1 ]
Tennagels, N. [1 ]
机构：
[1] Sanofi, Diabet Div, Frankfurt, Germany
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
296
引用
收藏
页码：A119 / A119
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Insulin Glargine 300U/mL versus 100U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
    Vargas-Uricoechea, Hernando
    [J]. JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [2] Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
    Steinstraesser, A.
    Schmidt, R.
    Bergmann, K.
    Dahmen, R.
    Becker, R. H. A.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (09): : 873 - 876
  • [3] Comparison of pharmacodynamics between insulin glargine 100 U/mL and insulin glargine 300 U/mL in healthy cats
    Saini, N. K.
    Wasik, B.
    Pires, J.
    Leale, D. M.
    Quach, N.
    Culp, W. T. N.
    Samms, R. J.
    Johnson, A. E.
    Owens, J. G.
    Gilor, C.
    [J]. DOMESTIC ANIMAL ENDOCRINOLOGY, 2021, 75
  • [4] Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
    Kovatchev, Boris
    Meng, Zhaoling
    Cali, Anna M. G.
    Perfetti, Riccardo
    Breton, Marc D.
    [J]. DIABETES THERAPY, 2020, 11 (06) : 1293 - 1302
  • [5] New insulin glargine 300U/ml (Gla-300): glycaemic control and hypoglycaemia in insulin-naive people with Type 2 diabetes compared with glargine 100U/ml (Gla-100)
    Bolli, G. B.
    Riddle, M. C.
    Bergenstal, R. M.
    Sestakauskas, K.
    Goyeau, H.
    Home, P. D.
    [J]. DIABETIC MEDICINE, 2015, 32 : 78 - 78
  • [6] Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
    Boris Kovatchev
    Zhaoling Meng
    Anna M. G. Cali
    Riccardo Perfetti
    Marc D. Breton
    [J]. Diabetes Therapy, 2020, 11 : 1293 - 1302
  • [7] New insulin glargine 300U/ml in people with Type 2 diabetes using basal insulin plus oral glucose lowering drugs compared with glargine 100U/ml (EDITION 2): less nocturnal hypoglycaemia and weight gain
    Home, P. D.
    Riddle, M. C.
    Bergenstal, R. M.
    Bolli, G. B.
    Wardecki, M.
    Maroccia, M.
    Yki-Jarvinen, H.
    [J]. DIABETIC MEDICINE, 2015, 32 : 78 - 79
  • [8] COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CROATIA
    Bogdanovic, M.
    Fournier, M.
    Vitezic, D.
    [J]. VALUE IN HEALTH, 2018, 21 : S131 - S132
  • [9] New insulin glargine 300U/ml in Type 2 diabetes using basal plus meal-time insulin: sustained glycaemic control and less hypoglycaemia compared with glargine 100U/ml (EDITION 1)
    Home, P. D.
    Yki-Jarvinen, H.
    Bolli, G. B.
    Cissokho, S.
    Riddle, M. C.
    [J]. DIABETIC MEDICINE, 2015, 32 : 78 - 78
  • [10] COST-UTILITY EVALUATION OF INSULIN GLARGINE (300 U/ML) VERSUS INSULIN GLARGINE (100 U/ML) AND INSULIN DEGLUDEC (100 U/ML) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN SERBIA
    Mihajlovic, J.
    Bogdanovic, M.
    Foumier, M.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A481 - A481
12345